Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03388788 · ClinicalTrials.gov registry record
Body Weight, Sleep, and Heart Health
A clinical trial of Obesity and Cardiovascular Risk Factor, sponsored by Oregon Health and Science University.
- Active
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT03388788 is a study of Obesity and Cardiovascular Risk Factor that is active but no longer recruiting, run by Oregon Health and Science University. The registered enrollment target is 16 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03388788, a study of Obesity and Cardiovascular Risk Factor, is active but no longer recruiting, sponsored by Oregon Health and Science University.
- ACTIVE NOT RECRUITING
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
A multidisciplinary investigation examining the circadian mechanisms regulating cardiovascular (CV) risk, with an additional focus on obesity. Specifically, in a valid circadian protocol, the investigators aim to study resting cardiovascular risk markers and the reactivity of circadian rhythms in these risk markers to standardized stressors. It is intended to compare results in lean and obese individuals to determine if there are specific risks across the circadian cycle specific to obesity. Furthermore, using an exploratory approach, the investigators propose to explore impairment in pre/post synaptic function in the cardiac left ventricle.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Positron Emission Tomography (PET) scanning of cardiac function at 3 time points across the 24 hour circadian cycle
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03388788
The ClinicalTrials.gov registry entry for NCT03388788 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Positron Emission Tomography (PET) scanning of cardiac function at 3 time points across the 24 hour circadian cycle is the first listed.
NCT03388788 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT03388788 about?
NCT03388788 is a clinical study titled "Body Weight, Sleep, and Heart Health". A multidisciplinary investigation examining the circadian mechanisms regulating cardiovascular (CV) risk, with an additional focus on obesity. Specifically, in a valid circadian protocol, the investigators aim to study resting cardiovascular risk markers and the reactivity of circadian rhythms in th...
What is the current status of trial NCT03388788?
This trial is currently active not recruiting. The enrollment target is 16 participants. The study started on 2018-05-01. Estimated completion is 2026-06-30.
What conditions does trial NCT03388788 study?
This clinical trial studies the following conditions: Obesity, Cardiovascular Risk Factor, Circadian Dysregulation.
What interventions are being tested in trial NCT03388788?
The interventions under investigation include: Positron Emission Tomography (PET) scanning of cardiac function at 3 time points across the 24 hour circadian cycle (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03388788?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03388788 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.